EXSCEL EXENATIDE STUDY OF CARDIOVASCULAR EVENT LOWERING Trademark

Trademark Overview


On Thursday, June 3, 2010, a trademark application was filed for EXSCEL EXENATIDE STUDY OF CARDIOVASCULAR EVENT LOWERING with the United States Patent and Trademark Office. The USPTO has given the EXSCEL EXENATIDE STUDY OF CARDIOVASCULAR EVENT LOWERING trademark a serial number of 85053858. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 12, 2011. This trademark is owned by Amylin Pharmaceuticals, Inc.. The EXSCEL EXENATIDE STUDY OF CARDIOVASCULAR EVENT LOWERING trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research, namely, conducting clinical trials for pharmaceutical preparations for the treatment of type 2 diabetes and their impact on cardiovascular disease
exscel exenatide study of cardiovascular event lowering

General Information


Serial Number85053858
Word MarkEXSCEL EXENATIDE STUDY OF CARDIOVASCULAR EVENT LOWERING
Filing DateThursday, June 3, 2010
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 12, 2011
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 15, 2011

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"EXENATIDE STUDY OF CARDIOVASCULAR EVENT LOWERING"
Description of MarkThe mark consists of the word "EXSCEL" in all capital letters. To the right of the word "EXSCEL" is a design image of a twisting band. The words "Exenatide Study of Cardiovascular Event Lowering" appear directly below the word "EXSCEL" and the design image in a smaller font.
Goods and ServicesMedical and scientific research, namely, conducting clinical trials for pharmaceutical preparations for the treatment of type 2 diabetes and their impact on cardiovascular disease
Pseudo MarkEXCEL EXENATIDE STUDY OF CARDIOVASCULAR EVENT LOWERING

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, June 9, 2010
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAmylin Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Party NameAmylin Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events


Event DateEvent Description
Monday, December 12, 2011ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, December 12, 2011ABANDONMENT - NO USE STATEMENT FILED
Tuesday, May 10, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 15, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 15, 2011PUBLISHED FOR OPPOSITION
Friday, February 4, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, February 1, 2011ASSIGNED TO LIE
Monday, January 3, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 2, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 2, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 2, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 13, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, September 13, 2010NON-FINAL ACTION E-MAILED
Monday, September 13, 2010NON-FINAL ACTION WRITTEN
Wednesday, September 8, 2010ASSIGNED TO EXAMINER
Thursday, June 10, 2010NOTICE OF DESIGN SEARCH CODE MAILED
Wednesday, June 9, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, June 7, 2010NEW APPLICATION ENTERED IN TRAM